Applied DNA Announces Third Quarter Fiscal 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Vertiv shares fall on analyst downgrades and options bets
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
- S&P 500 ends higher as traders shift from AI to healthcare
- Caterpillar names Derrick York to lead Resource Industries
- Most Asian stocks rise as calm returns after CoreWeave shock; Indonesia faces market downgrade
Applied DNA Sciences (APDN) Misses Q3 EPS by 24c
August 12, 2021 4:30 PM EDTApplied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.46), $0.24 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $3.13 million.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
... More


